The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy
- 5 July 2022
- journal article
- research article
- Published by Elsevier in Surgical Oncology
- Vol. 43, 101809
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Positron Emission Tomography (PET) in OncologyCancers, 2014
- Oesophageal carcinomaThe Lancet, 2013
- Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancerThoracic Cancer, 2012
- Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Phase III Trial of Protracted Compared With Split-Course Chemoradiation for Esophageal Carcinoma: Fédération Francophone de Cancérologie Digestive 9102Journal of Clinical Oncology, 2007
- Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102Journal of Clinical Oncology, 2007
- Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the EsophagusJournal of Clinical Oncology, 2005
- Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal CancerClinical Nuclear Medicine, 2000
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992